Sign Up Today and Learn More About Qkine Stock
Invest in or calculate the value of your shares in Qkine or other pre-IPO companies through EquityZen's platform.
Qkine Stock (QKIN)
Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications
About Qkine Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
Qkine Press Mentions
Stay in the know about the latest news on Qkine
TrumpRx and Medicare highlight shifting pharma industry priorities, says GlobalData
pharmiweb • Mar 17, 2026
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
prnewswire • Feb 12, 2026
Biologics Safety Testing Market to Rise at 13.64% CAGR, Soars USD 14.45 Bn by 2034
globenewswire • Oct 17, 2025
Next-Generation Therapy Market Growth, Trends and Competitive Strategies – Towards Healthcare
globenewswire • Oct 13, 2025
Qkine alliance with Culturon promises advances in stem cell and life science
businessweekly • Jan 08, 2025
Qkine Management
Leadership team at Qkine
CEO & Founder
Catherine Elton
Director & Foundr
Marko Hyvönen
Join now and verify your accreditation status to gain access to:
- Qkine Current Valuation
- Qkine Stock Price
- Qkine Management
- Available deals in Qkine and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Qkine Cap Table and Funding History by Share Class and Liquidity Preferences
- Qkine Revenue and Financials
- Qkine Highlights
- Qkine Business Model
- Qkine Risk Factors
- Qkine Research Report from SACRA Research
Trading Qkine Stock
How to invest in Qkine stock?
Accredited investors can buy pre-IPO stock in companies like Qkine through EquityZen funds. These investments are made available by existing Qkine shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Qkine stock?
Shareholders can sell their Qkine stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
